Announcement on Voluntary Disclosure of the Approval for Market Launch of Izaberonramab (BL-B01D1/iza-bren)

About this update from Sichuan Biokin Pharmaceutical Co., Ltd. Class A

Announcement on Voluntary Disclosure of the Approval for Market Launch of Izaberonramab (BL-B01D1/iza-bren) The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sichuan Biokin Pharmaceutical Co., Ltd. Class A